In the last couple of years, a record number of
personalized therapeutic products were approved in the US, establishing an
urgent need for companion diagnostics and causing many drug developers to
actively seek external support and expertise
Roots Analysis is pleased to announce the publication of its recent
study, titled, “Companion
Diagnostics Development Services Market, 2020-2030”
The report features an extensive study of the current
market landscape, offering an informed opinion on the likely adoption of
diagnostic development services over the next decade. It features an in-depth
analysis, highlighting the capabilities of the various stakeholders in this
domain. In addition to other elements, the study includes:
§
A detailed assessment of the current market landscape of more
than 180 companies offering companion diagnostics services.
§
Tabulated profiles of companion diagnostics service
providers (shortlisted on the basis of the number of services offered).
§
An analysis of the partnerships that have been established
in this domain, in the recent past.
§
A list of stakeholders generated based on a detailed
analysis of a set of relevant parameters, which are anticipated to partner with
companion diagnostics services providers in the foreseen future.
§
A detailed
competitiveness analysis of companion diagnostics services providers, featuring
insightful pictorial summaries and representations.
§
A comparative analysis of the needs of different
stakeholders involved in this domain.
§
A discussion on various steps of the development operations
of a companion diagnostic and the cost requirements across each of the stages.
§
An analysis of completed, ongoing and planned clinical
trials featuring disease-specific biomarkers.
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
§
Feasibility Studies
§
Assay Development
§
Analytical Validation
§
Clinical Validation
§
Manufacturing
- Type
of Analytical Technique
§
in situ hybridization / Immunohistochemistry
§
Next Generation Sequencing
§
Polymerase Chain Reaction
§
Others
§
North America
§
Europe
§
Asia-Pacific and the Rest of the World
Transcripts of interviews held with the following senior
level representatives of stakeholder companies
§
Anton Iliuk (President, Chief Technology Officer Tymora
Analytical Operations)
§
Paul Kortschak (Senior Vice President, Novodiax)
§
Pablo Ortiz (Chief Executive Officer, OWL Metabolomics)
§
Lawrence M. Weiss (Chief Scientific Officer, NeoGenomics
Laboratories)
Key
companies covered in the report
§
Almac Diagnostic Services
§
Asuragen
§
BARD1 Life Sciences
§
BioMarCare Technologies
§
Covance
§
Gencurix
§
Geneuity
§
Leica Biosystems
§
Macrogen
§
MD Biosciences
§
R-Biopharm
§
ResearchDx
§
Tepnel Pharma Services
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html
Other Recent Offerings
1.
Neoantigen
Targeted Therapies Market, 2019-2030
2.
Bispecific
Antibody Therapeutics Market (4th Edition), 2019-2030
3.
Global
Stem Cells Market: Focus on Clinical Therapies, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market
research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com